Computational evidence
| Protein change | ||
| AlphaMissense | 0.1376 | likely benign |
|---|---|---|
| REVEL | 0.059 | moderately benign-leaning |
| SaProt | LLR -6.08 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.4 | GERP 1, phastCons 1 |
| Regional constraint | o/e 1.06 | unconstrained · MANE · 31 kb · p 0.1 · regional, not allelic |
| Overall | ||
| CADD | 15.37 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 66.4% | 2 |
| Amishnot grpmax-eligible | 64.7% | 2 |
| European (non-Finnish)grpmax | 62.2% | 2 |
| South Asian | 62% | 2 |
| Ashkenazi Jewishnot grpmax-eligible | 61.5% | 2 |
| Middle Eastern | 60.8% | 2 |
| Remaining individualsnot grpmax-eligible | 57.7% | 2 |
| Admixed American | 41.5% | 2 |
| African / African-American | 29.6% | 3 |
| East Asian | 16.4% | 6 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- RNF168
- Protein
- p.Pro401Gln
- Coding
- c.1202C>A
- MANE Select
- NM_152617
- dbSNP
- rs3796129
- Type
- single nucleotide variant
- Location
- chr3:196472333 (GRCh38)
- Gene constraint
- LOEUF 1.406 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 61.97 · 39 PDB
- Residue 401
- a UniProt-annotated variant site (in); the 'disordered' region
Similar variants
- RNF168 p.Pro401Leu Uncertain significance ★ ⚠ same residue
- RNF168 p.Arg131Ter Pathogenic/Likely pathogenic ★★ same condition
- RNF168 p.Arg165Ter Pathogenic/Likely pathogenic ★★ same condition
- RNF168 p.Glu138Ter Pathogenic/Likely pathogenic ★★ same condition
- RNF168 p.Glu157Gly Uncertain significance ★★ ⚠ same condition
- RNF168 p.Glu307Lys Uncertain significance ★★ ⚠ same condition
- RNF168 p.Ile79Met Uncertain significance ★★ ⚠ same condition
- RNF168 p.Ser340Leu Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rnf168-p-pro401gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown